| Belltower Health & Rehabilitation Center | |
| 5805 North Fir Road, Granger, Indiana 46530 | |
| (574) 406-6600 | |
| Name | Belltower Health & Rehabilitation Center |
|---|---|
| Location | 5805 North Fir Road, Granger, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 96 |
| Occupancy Rate | 67.4% |
| Medicare ID (CCN) | 155850 |
| Legal Business Name | Major Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1164885372 |
| Organization Name | MAJOR HOSPITAL |
| Doing Business As | BELLTOWER HEALTH & REHABILITATION CENTER |
| Address | 5805 N. Fir Rd., Granger, IN 46530 |
| Phone Number | 317-392-3211 |
News Archive
For patients with kidney failure, poor kidney function and immunosuppressant medications may increase their risk of developing different types of cancer. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology, suggest the need for persistent cancer screening and prevention in these patients.
Washington state's "patchwork of programs, pilot projects and other efforts" reflected in the health overhaul could give it a head start on implementing the new law, The Seattle Times reports.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Now, a study by researchers from the University of California has shown that the N protein forms biomolecular condensates with the viral RNA in both in vitro and in vivo studies. The research titled, ‘SARS CoV-2 nucleocapsid protein forms condensates with viral genomic RNA', was published on the preprint server bioRxiv on September 14th, 2020.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
For patients with kidney failure, poor kidney function and immunosuppressant medications may increase their risk of developing different types of cancer. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology, suggest the need for persistent cancer screening and prevention in these patients.
Washington state's "patchwork of programs, pilot projects and other efforts" reflected in the health overhaul could give it a head start on implementing the new law, The Seattle Times reports.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Now, a study by researchers from the University of California has shown that the N protein forms biomolecular condensates with the viral RNA in both in vitro and in vivo studies. The research titled, ‘SARS CoV-2 nucleocapsid protein forms condensates with viral genomic RNA', was published on the preprint server bioRxiv on September 14th, 2020.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $12675 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.43 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.9 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.53 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.69 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 20.58 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.38 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.37 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.09 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 57.23 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.71 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 50.64 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.43 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.98 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.59 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.25 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.4 | 82.93 |
News Archive
For patients with kidney failure, poor kidney function and immunosuppressant medications may increase their risk of developing different types of cancer. The findings, which are published in a study appearing in an upcoming issue of the Journal of the American Society of Nephrology, suggest the need for persistent cancer screening and prevention in these patients.
Washington state's "patchwork of programs, pilot projects and other efforts" reflected in the health overhaul could give it a head start on implementing the new law, The Seattle Times reports.
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that it has initiated a Phase 1 clinical study of HTL9936, the first fully selective muscarinic M1 receptor agonist to enter clinical development. HTL9936 is an orally available, small molecule drug candidate discovered using the Heptares GPCR structure-based drug design platform.
A recent report by the Institute of Medicine (IOM) confirmed that 3.5 to 5.3 million people (1-2 % of the U.S. population) have chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Despite efforts by federal, state and local government agencies to control and prevent these diseases, they remain a serious public health concern. The major factor impeding efforts to control HBV and HCV is lack of knowledge and awareness among health care providers, social service professionals, members of the public, and policy-makers.
Now, a study by researchers from the University of California has shown that the N protein forms biomolecular condensates with the viral RNA in both in vitro and in vivo studies. The research titled, ‘SARS CoV-2 nucleocapsid protein forms condensates with viral genomic RNA', was published on the preprint server bioRxiv on September 14th, 2020.
› Verified 1 days ago
Belltower Health & Rehabilitation Center Location: 5805 North Fir Road, Granger, Indiana 46530 Phone: (574) 406-6600 |